Oculis Statistics
NASDAQ: OCSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.06-0.38 (-5.11%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Oculis by the numbers
Oculis has a market capitalization of $393.4 million based on 55.72M shares outstanding. With trailing EPS of $-1.69, Oculis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.2% below its 50-day average and 59.3% below its 200-day average.
Average daily trading volume is 272.83K shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OCS valuation vs. peer median
| Metric | OCS | Peer median | Difference |
|---|---|---|---|
| Market cap | $393.35M | $403.05M | -2% |
| Avg. volume | 272.83K | 1.44M | -81% |
Peer median across 8 companies: AVTX, IRD, PHAT, OVID, CRMD, PRTA, PBYI, ARVN.
Valuation
- Market cap
- $393.35M
- EPS (TTM)
- $-1.69
- Shares outstanding
- 55.72M
Price and trading
- Previous close
- 7.44
- Open
- 7.38
- Day range
- 6.99 – 7.43
- 52-week range
- 6.78 – 34.48
- 52-week change
- -63.34%
- Beta
- —
- Volume
- 235.18K
- Average volume
- 272.83K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 393.35M
- Forward Pe
- -3.92
- Eps
- -1.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 34.48
- Week52 Low
- 6.78
- Avg Volume
- 272.83K
- Shares Outstanding
- 55.72M
- Ma50
- 8.33
- Ma200
- 17.35
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -79.52%
- Pct From52w Low
- 4.13%